Avanos Medical, Inc. (AVNS) P/E Ratio History
Insufficient DataValuation data unavailable. · Data 2014–2024
Loading P/E history...
P/E Ratio Analysis
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our AVNS DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
AVNS Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
AVNS P/E vs Peers
Hospital Supplies & Medtech OEM peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $5B | 32.9 | - | +5% | |
| $4B | 42.2 | 9.59 | -15% | |
| $3B | 196.0 | - | +75% | |
| $4B | 71.7 | - | +101% | |
| $1B | 7.1Lowest | 0.69Best | +817%Best | |
| $131B | 25.0 | 3.58 | +3% | |
| $64B | 17.8 | - | +55% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
AVNS Historical P/E Data (2014–2024)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2024 Q3 | Sep 30 2024 | $24.03 | $0.34 | 70.3x | -48% |
| FY2024 Q2 | Jun 30 2024 | $19.92 | $0.17 | 116.8x | -13% |
| FY2023 Q1 | Mar 31 2023 | $29.74 | $0.92 | 32.4x | -76% |
| FY2022 Q4 | Dec 31 2022 | $27.06 | $1.05 | 25.8x | -81% |
| FY2022 Q3 | Sep 30 2022 | $21.78 | $0.90 | 24.2x | -82% |
| FY2022 Q1 | - | $33.50 | $0.38 | 88.2x | -35% |
| FY2021 Q4 | Dec 31 2021 | $34.67 | $0.10 | 346.7x | +157% |
| FY2021 Q2 | Jun 30 2021 | $36.37 | $0.03 | 1212.3x | +799% |
| FY2020 Q3 | Sep 30 2020 | $33.22 | $0.29 | 115.7x | -14% |
| FY2019 Q1 | Mar 31 2019 | $42.68 | $0.34 | 124.2x | -8% |
| FY2018 Q4 | Dec 31 2018 | $44.79 | $0.53 | 84.1x | -38% |
| FY2018 Q3 | Sep 30 2018 | $68.50 | $1.28 | 53.6x | -60% |
| FY2018 Q2 | Jun 30 2018 | $57.25 | $1.54 | 37.2x | -72% |
| FY2018 Q1 | Mar 31 2018 | $46.08 | $1.18 | 39.1x | -71% |
| FY2017 Q4 | Dec 31 2017 | $46.18 | $1.69 | 27.3x | -80% |
| FY2017 Q3 | Sep 30 2017 | $45.03 | $1.20 | 37.5x | -72% |
| FY2017 Q2 | Jun 30 2017 | $39.28 | $1.04 | 37.8x | -72% |
| FY2017 Q1 | Mar 31 2017 | $38.09 | $0.81 | 47.0x | -65% |
| FY2016 Q4 | Dec 31 2016 | $36.98 | $0.84 | 44.0x | -67% |
| FY2016 Q3 | Sep 30 2016 | $34.66 | $0.94 | 36.9x | -73% |
| FY2015 Q2 | - | $40.50 | $0.42 | 96.8x | -28% |
| FY2015 Q1 | - | $49.20 | $0.15 | 324.3x | +141% |
| FY2014 Q4 | Dec 31 2014 | $45.47 | $0.58 | 78.2x | -42% |
Average P/E for displayed period: 134.8x
AVNS Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
12+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
AVNS — Frequently Asked Questions
Quick answers to the most common questions about buying AVNS stock.
What is AVNS's P/E ratio?
Avanos Medical, Inc. (AVNS) trailing twelve-month P/E ratio is N/A, based on TTM diluted EPS of N/A. The 5-year average P/E is 130.0x and the historical range spans 24.2x to 1212.3x.
Is AVNS stock overvalued or undervalued?
AVNS current P/E: N/A. 5-year average P/E: 130.0x. Percentile: N/A.
Is AVNS stock expensive?
AVNS is fairly valued relative to its own history. The current P/E of N/A is near the 5-year average of 130.0x (N/A percentile of historical range).
What is AVNS's historical P/E range?
Over the past 5 years, AVNS's P/E ratio has ranged from 24.2x to 1212.3x, with a median of 47.0x and an average of 130.0x. The current P/E of N/A places the stock at the N/A percentile of this range. Full historical data spans 2014–2024.
How does AVNS's P/E compare to the S&P 500?
AVNS current P/E: N/A. S&P 500 median P/E: 21.8x.
How does AVNS's valuation compare to Healthcare peers?
Avanos Medical, Inc. P/E of N/A can be benchmarked against Healthcare peers in the comparison table on this page.
What is AVNS's PEG ratio?
AVNS PEG ratio is N/A. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is AVNS's earnings yield?
AVNS earnings yield is N/A, the inverse of its N/A P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.